Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2010
05/26/2010CN101020715B Process of extracting and preparing deer nerve growth factor (DEER NGF)
05/25/2010US7723589 Plants and seeds of corn variety CV688430
05/25/2010US7723573 Rubisco activase with increased thermostability and methods of use thereof
05/25/2010US7723572 Polynucleotide encoding polypeptide having aspartate kinase activity; transforming cell for development of nutritionally improved crop plants
05/25/2010US7723565 Expression vector comprising nucleotide sequences associated with vernalization-3 gene (VIN-3); controlling flowering in crops; improving heterologous gene expression
05/25/2010US7723563 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto
05/25/2010US7723505 EAAT2 promoter and uses thereof
05/25/2010US7723504 Nontypeable Haemophilus influenzae virulence factors
05/25/2010US7723501 polynucleotides tht code for Bcl-2 associated athanogenes (BAG), a family of proteins that can regulate protein folding, useful in modulating chaperone protein activity
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723499 polynucleotides that code for polypeptides comprising amino acid sequences that preferentially recognize and bind to angiopoietins
05/25/2010US7723498 as biocatalysts in industrial chemical redox reactions, such as the oxidation of aromatic hydrocarbons, for example, toluene, benzene, or nitrobenzene, into industrially desirable products
05/25/2010US7723496 Tumor antigen for diagnosis and treatment of cell proliferative disorders
05/25/2010US7723492 Method for the detection of sepsis using procalcitonin-3-116
05/25/2010US7723491 extracting proteinaceous growth factors from bovine through chromatography, solvent extraction, precipitation, centrifugation; biological substances purification
05/25/2010US7723490 Process for correction of a disulfide misfold in Fc molecules
05/25/2010US7723488 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders
05/25/2010US7723487 Method for purifying cancer-specific proliferating cell nuclear antigen
05/25/2010US7723486 antibody that binds to human TGF beta 1, TGF beta 2 and TGF beta 3, comprising the PET1073G12 heavy chain variable domain (SEQ ID NO: 2) and the PET1073G12 light chain variable domain (SEQ ID NO: 7), or an isolated segment of the antibody
05/25/2010US7723484 Epidermal growth factor specific immunoglobulin for use in treatment and prevention cell proliferative disorders
05/25/2010US7723483 An antibody binding to the cysteine loop domain at amino acids 177-184 of a human or pig beta 3 integrin (Amino Acid SEQ ID NO: 82); does not bind to the RGD binding site of a human beta 3 integrin or utilize the RGD binding site of human beta 3 integrin; side effect reduction; nontoxic
05/25/2010US7723481 G protein coupled receptor (GPCR) polypeptide, attached to a detectable label seleacted from green fluorescent polypeptide or a rhodopsin polypeptide, involved in bitter taste transduction; used as additives for foods, beverages and drugs in order to modify T2R-associated bitter taste
05/25/2010US7723480 Leucine-based motif and clostridial neurotoxins
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723478 DKR polypeptides
05/25/2010US7723477 Frizzled receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
05/25/2010US7723476 Anticalins
05/25/2010US7723475 isolated nucleic acid molecule encoding polypeptide as antitumor biodrugs; monoclonal antibody; modulation of chemokine, cytokine expression; transfected host cell; anticarcinogenic agents
05/25/2010US7723473 Peptide antagonists of TGF-beta family members and therapeutic uses thereof
05/25/2010US7723471 Useful in the treatment and prevention of metabolic disorders; promote weight loss; hypotensive, antisecretory, and gastroprotective agents
05/25/2010US7723469 Treating leukemia by administering a cross-linked polypeptide antiapoptosis agent having at least two modified amino acids ("hydrocarbon stapling"); crosslinking increases cell permeability
05/25/2010US7723468 Antimicrobial peptide, compositions, and uses therefor
05/25/2010US7723308 Plant-derived elastin binding protein ligands and methods of using the same
05/25/2010US7723302 Method of treating Parkinson's disease
05/25/2010US7723300 Regulators of the non-genomic action of progesterone and methods of use
05/25/2010US7723299 Methods for treating rheumatoid arthritis using a CTLA-4 fusion protein
05/25/2010US7723298 Cytokine receptor
05/25/2010US7723297 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence
05/25/2010US7723296 Coupling monosaccharide into glycoprotein; oxidation; increasing therapeutic efficiency
05/25/2010US7723109 Expression of spider silk proteins
05/25/2010US7723104 Polynucleotide construct having a prostate cancer-specific control sequence including at least 2 of a prostate tissue-specific control sequence; a cancer-specific control sequence; and a two-step transcriptional amplification sequence including a DNA binding domain and an activation domain
05/25/2010US7723096 Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides
05/25/2010US7723092 Chondroitin polymerase and DNA encoding the same
05/25/2010US7723087 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides
05/25/2010US7723082 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives
05/25/2010US7723075 Methods of screening for TRPM5 modulators
05/25/2010US7723074 Nucleic acid molecules encoding prostaglandin receptor proteins
05/25/2010US7723072 Using cadmium-zinc resistance (CZR) protein as modulator for enhancing exogenous gene expression
05/25/2010US7723071 DNA molecules encoding opioid receptors and methods of use thereof
05/25/2010US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering
05/25/2010US7723063 Competitive Enzyme-Linked Immunosorbent Assay using an oxidativly-folded hepcidin polypeptide covalently linked to a hydrophilic spacer that is 2-(2-(aminoethoxy)ethoxy)acetic at the amino terminus of the peptide and to biotin; immobilized antibody
05/25/2010US7723051 HT2R75 taste receptor and related assays for identifying human bitter taste modulators
05/25/2010US7723049 Marker for inflammatory conditions
05/25/2010US7723046 Method of screening for a compound using guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37
05/25/2010US7723042 Using parathyroid receptor epitope binding activity as a diagnostic indicator concentration of parathyroid hormone; diagnosing hyper/hypo-parathyroidism
05/25/2010US7723027 Using presence of mutation in neuronal sodium channel (SCN1) to diagnose severe myoclonic epilepsy of infancy (SMEI)
05/25/2010US7723024 by measuring zinc regulated nucleic acid molecules expression level indicative of sub-optimal fermentation in a beer brewing
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010US7723021 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases
05/25/2010US7723019 Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof
05/25/2010US7722895 Osteogenic implants with combined implant materials, and materials and methods for same
05/25/2010US7722889 Plasmodium liver stage antigens
05/25/2010US7722888 Streptococcus pneumoniae proteins and nucleic
05/25/2010US7722887 detoxified and immunologically active heat-labile enterotoxin protein of Escherichia coli, wherein the serine residue at position 63 is substituted with tyrosine or amino acid residues at positions 110 and 112 are deleted; for development of a mucosal vaccine as well as a novel diarrheal vaccine
05/25/2010US7722883 Genetic vaccine against PWD circovirus
05/25/2010US7722882 Live attenuated vaccine against porcine pleuropneumonia
05/25/2010US7722880 polynucleotide encodes a protein for inducing an immune response; use as vaccines; drug targeting to specific protein; bactericides; veterinary medicine
05/25/2010US7722879 amino acid sequence proteins or immunogenic fragments, encoded sequence from isolated nucleic acid; for treating infection caused from Babesiidae; diagnostic test for the detection of nucleic acids, antibodies or antigens of the organism; safe, stable, easily scaleable production; veterinary medicine
05/25/2010US7722877 Coccidiosis vaccines
05/25/2010US7722876 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity
05/25/2010US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells
05/25/2010US7722872 Treatment of cancer with antibodies to costimulating polypeptide of T cells
05/25/2010US7722870 Method of treating fibroproliferative disorders
05/25/2010US7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof
05/25/2010US7722861 Attenuated Mycobacterium tuberculosis vaccines
05/25/2010CA2488697C Regulation of gene expression using chromatin remodelling factors
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2361892C Treatment of tumors with genetically engineered herpes virus
05/25/2010CA2354928C Non-mucin type synthetic compounds or it's carrier conjugated compounds
05/25/2010CA2313248C Process for the production of naturally folded and secreted proteins by co-secretion of molecular chaperones
05/25/2010CA2248243C Purification of tissue plasminogen activator (tpa)
05/25/2010CA2241786C Novel amp activated protein kinase
05/25/2010CA2233538C Commercial production of aprotinin in plants
05/25/2010CA2225189C Canine factor viii gene, protein and methods of use
05/25/2010CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions
05/25/2010CA2195446C Growth control for cells encapsulated within bioartificial organs
05/25/2010CA2167178C Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity
05/20/2010WO2010057203A2 Hdl particles for delivery of nucleic acids
05/20/2010WO2010057175A1 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
05/20/2010WO2010057032A2 Self-assembly of protein-based biomaterials with multiple morphologies
05/20/2010WO2010056970A2 Optically-based stimulation of target cells and modifications thereto
05/20/2010WO2010056966A2 Novel hiv-2 isolate
05/20/2010WO2010056808A2 Compositions and methods for re-programming and re-differentiating cells
05/20/2010WO2010056796A1 Human m2e peptide immunogens
05/20/2010WO2010056584A1 Method of producing serum-free insulin-free factor vii
05/20/2010WO2010056472A2 Compositions and methods of use for thrombomodulin variants
05/20/2010WO2010056399A1 Method and composition for modulating the immune system and various inflammatory conditions comprising complement depletors
05/20/2010WO2010056108A2 Extract having protease activity
05/20/2010WO2010055500A1 A vaccinia virus protein a46 peptide and use thereof
05/20/2010WO2010055358A1 Suppression of cancer
1 ... 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 ... 2916